2019 Q2/Global Life Sciences
Rank | Chg | Organisation name | Overall |
|
---|---|---|---|---|
|
||||
1 | +8 |
Pfizer UK
|
7.5 | |
|
||||
2 | -1 |
Cytogen
|
6.4 | |
|
||||
3 | +0 |
Ligand Pharmaceuticals
|
6.3 | |
|
||||
4 | +2 |
Shionogi
|
6.0 | |
|
||||
5 | +7 |
Dainippon Sumitomo
|
5.8 | |
|
||||
6 | +5 |
Yakult UK
|
5.6 | |
|
||||
7 | +18 |
Galenica AG
|
5.5 | |
|
||||
8 | +0 |
Baxter Healthcare UK
|
5.5 | |
|
||||
9 | +134 |
Alcon
|
5.4 | |
|
||||
10 | +5 |
Hetero
|
5.4 | |
|
||||
11 | -1 |
Wockhardt
|
5.4 | |
|
||||
12 | -4 |
Genus
|
5.3 | |
|
||||
13 | +11 |
QLT
|
5.3 | |
|
||||
14 | +12 |
Kyorin Holdings
|
5.3 | |
|
||||
15 | -11 |
Zambon
|
5.2 | |
|
||||
16 | +65 |
Medivir Group
|
5.2 | |
|
||||
17 | +31 |
Debiopharm
|
5.1 | |
|
||||
18 | +9 |
Abbott Uk
|
5.1 | |
|
||||
19 | -5 |
GlaxoSmithKline
|
5.0 | |
|
||||
20 | -1 |
Piramel Enterprises
|
5.0 | |
|
||||
21 | +0 |
Bosnalijek
|
5.0 | |
|
||||
22 | +14 |
Takeda UK
|
5.0 | |
|
||||
23 | +0 |
EISAI UK
|
4.9 | |
|
||||
24 | +7 |
Apotex
|
4.8 | |
|
||||
25 | -20 |
Kyowa Hakko Kirin
|
4.8 | |
|
||||
26 | +23 |
Recordati
|
4.8 | |
|
||||
27 | +7 |
ALK-Abello
|
4.8 | |
|
||||
28 | +11 |
Lexicon Pharmaceuticals
|
4.8 | |
|
||||
29 | +6 |
Laboratoires Thea UK
|
4.8 | |
|
||||
30 | +8 |
Lilly
|
4.7 | |
|
||||
31 | +136 |
Patheon
|
4.7 | |
|
||||
32 | +8 |
Bavarian Nordic
|
4.7 | |
|
||||
33 | -20 |
Actelion
|
4.7 | |
|
||||
34 | -18 |
Santen
|
4.6 | |
|
||||
35 | -6 |
Zandu
|
4.6 | |
|
||||
36 | +88 |
EISAI
|
4.6 | |
|
||||
37 | -30 |
Baxter International
|
4.5 | |
|
||||
38 | +78 |
Nippon Kayaku
|
4.5 | |
|
||||
39 | -9 |
Toray Industries
|
4.5 | |
|
||||
40 | -3 |
Acorda Therapeutics
|
4.5 | |
|
||||
41 | +23 |
Esteve
|
4.5 | |
|
||||
42 | +14 |
Mitsubishi Tanabe
|
4.5 | |
|
||||
43 | +95 |
Teijin Europe
|
4.5 | |
|
||||
44 | -11 |
ProMetric Life Sciences
|
4.5 | |
|
||||
45 | +9 |
Bial Portela
|
4.5 | |
|
||||
46 | +0 |
Wockhardt UK
|
4.4 | |
|
||||
47 | -27 |
Takeda
|
4.4 | |
|
||||
48 | +19 |
Santen Europe
|
4.4 | |
|
||||
49 | +4 |
Leo Pharma UK
|
4.4 | |
|
||||
50 | -22 |
Otsuka Pharmaceuticals Europe
|
4.3 | |
|
Changes in rank are compared to 2019 Q1/Global Life Sciences. Since then, 3 sites entered the survey and 85 sites could not be included in the rankings (4 more since last time). Build your own. Report statistics.
Priorities Summary
The priorities for this organization are not currently available to view.
Contact Us